spacer
home > pmps > spring 2019 > maintaining security and sterility
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Maintaining Security and Sterility

Many of today’s newer pharmaceutical formulas require more stringent moisture, light, or oxygen protection. Formulas are also becoming more potent, leading to demand for metered dosing in small tube diameters for low (yet powerful) fill volumes. Here, small high-barrier tubes offer attractive user-friendliness and can diminish over-packaging by eliminating the need for secondary packaging like pouches and barrier blisters. They can also provide increased safety through simplicity: the fewer ‘moving parts’ a package has, the lower the likelihood of accidental misuse by end-users.

The Tube Packaging Market

Looking at the larger picture, it is interesting to note that, according to MarketsandMarkets, the worldwide tube packaging market is projected to grow at a compound annual growth rate of 6.9% during the forecast period of 2016 to 2021, approaching US $9.3 billion by 2021 (1).

The tube packaging market is gaining momentum due to factors that include overall growth in the flexible packaging sector and increased demand for small size packs for cosmetic and personal care products. Additional factors driving the market are advancements in tube technologies and, as previously noted, heightened demand for enhanced barrier properties to protect sensitive pharmaceutical products.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Martina Christiansen is Head of Sales and Marketing Pharmaceutical at Hoffmann Neopac, a global provider of high-quality tube packaging for a broad array of industries and applications.
spacer
Martina Christiansen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement